Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Osteoporosis 1Obesity 1Hypertension 1Hypercholesterolemia 1Diabetes Mellitus 1Cushing Syndrome 1Adrenal incidentaloma 1Adrenal Gland Neoplasms 1

Interventions

Vitamin D 2Tirzepatide 2Metformin 2licogliflozin 1indole-3-carbinol 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Tablets 1Specimen Handling 1Resistance Training 1Progestins 1Pregabalin 1Orlistat 1Organizational Objectives 1Omeprazole 1Observation 1Naltrexone 1Ketorolac 1Exergaming 1Exercise 1Exenatide 1Diet, Plant-Based 1Dexmedetomidine 1Dalteparin 1Counseling 1Cholecalciferol 1Calcium Citrate 1Calcium Carbonate 1Calcitriol 1CKD732 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Obesity × Adrenalectomy × Clear all
NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡